3-Methyl-2-oxobutanoic acid

3-Methyl-2-oxobutanoic acid is a lipid of Fatty Acyls (FA) class. 3-methyl-2-oxobutanoic acid is associated with abnormalities such as Maple Syrup Urine Disease and Kidney Failure, Chronic. The involved functions are known as Phosphorylation, Citric Acid Cycle, inhibitors, Process and Metabolic Control. 3-methyl-2-oxobutanoic acid often locates in Mitochondria, BL21, Cytoplasm, Ribosomes and Head. The associated genes with 3-Methyl-2-oxobutanoic acid are Genome, Homologous Gene, Operon, Alleles and Oxidoreductase Gene. The related lipids are dimyristoylphosphatidylglycerol, 9-oxononanoic acid, Valerates and alpha-ketocaproic acid.

Cross Reference

Introduction

To understand associated biological information of 3-Methyl-2-oxobutanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 3-Methyl-2-oxobutanoic acid?

3-Methyl-2-oxobutanoic acid is suspected in Maple Syrup Urine Disease, Kidney Failure, Chronic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 3-Methyl-2-oxobutanoic acid

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Ketosis D007662 13 associated lipids
Body Weight D001835 333 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Per page 10 20 50 | Total 31

PubChem Associated disorders and diseases

What pathways are associated with 3-Methyl-2-oxobutanoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 3-Methyl-2-oxobutanoic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 3-Methyl-2-oxobutanoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 3-Methyl-2-oxobutanoic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 3-Methyl-2-oxobutanoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 3-Methyl-2-oxobutanoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 3-Methyl-2-oxobutanoic acid

Download all related citations
Per page 10 20 50 100 | Total 726
Authors Title Published Journal PubMed Link
Zhang M et al. C metabolic flux profiling of Pichia pastoris grown in aerobic batch cultures on glucose revealed high relative anabolic use of TCA cycle and limited incorporation of provided precursors of branched-chain amino acids. 2017 FEBS J. pmid:28731268
Fukai K et al. Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men. 2016 PLoS ONE pmid:27741291
Heemskerk MM et al. Reanalysis of mGWAS results and in vitro validation show that lactate dehydrogenase interacts with branched-chain amino acid metabolism. 2016 Eur. J. Hum. Genet. pmid:26014429
Song Y et al. Biotechnological production of alpha-keto acids: Current status and perspectives. 2016 Bioresour. Technol. pmid:27575335
Kim J et al. Calmodulin-mediated suppression of 2-ketoisovalerate reductase in Beauveria bassiana beauvericin biosynthetic pathway. 2016 Environ. Microbiol. pmid:27449895
Shibata K et al. High-performance liquid chromatographic method for profiling 2-oxo acids in urine and its application in evaluating vitamin status in rats. 2016 Biosci. Biotechnol. Biochem. pmid:26745680
Chen X et al. Production of C4 and C5 branched-chain alcohols by engineered Escherichia. coli. 2015 J. Ind. Microbiol. Biotechnol. pmid:26350079
Lee DW et al. Increased valinomycin production in mutants of Streptomyces sp. M10 defective in bafilomycin biosynthesis and branched-chain α-keto acid dehydrogenase complex expression. 2015 J. Ind. Microbiol. Biotechnol. pmid:26335568
Sommer B et al. Detailed structure-function correlations of Bacillus subtilis acetolactate synthase. 2015 Chembiochem pmid:25393087
Lu J et al. Characterization and modification of enzymes in the 2-ketoisovalerate biosynthesis pathway of Ralstonia eutropha H16. 2015 Appl. Microbiol. Biotechnol. pmid:25081555
Bückle-Vallant V et al. Metabolic engineering of Corynebacterium glutamicum for 2-ketoisocaproate production. 2014 Appl. Microbiol. Biotechnol. pmid:24169948
Lang K et al. Metabolic engineering of Pseudomonas sp. strain VLB120 as platform biocatalyst for the production of isobutyric acid and other secondary metabolites. 2014 Microb. Cell Fact. pmid:24397404
Panten U et al. Acute metabolic amplification of insulin secretion in mouse islets is mediated by mitochondrial export of metabolites, but not by mitochondrial energy generation. 2013 Metab. Clin. Exp. pmid:23790612
Buchholz J et al. Platform engineering of Corynebacterium glutamicum with reduced pyruvate dehydrogenase complex activity for improved production of L-lysine, L-valine, and 2-ketoisovalerate. 2013 Appl. Environ. Microbiol. pmid:23835179
Miyanoiri Y et al. Differential isotope-labeling for Leu and Val residues in a protein by E. coli cellular expression using stereo-specifically methyl labeled amino acids. 2013 J. Biomol. NMR pmid:24057411
Boulangé CL et al. Early metabolic adaptation in C57BL/6 mice resistant to high fat diet induced weight gain involves an activation of mitochondrial oxidative pathways. 2013 J. Proteome Res. pmid:23473242
Saylor PJ et al. Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer. 2012 Clin. Cancer Res. pmid:22589396
Jia X et al. Engineering a metabolic pathway for isobutanol biosynthesis in Bacillus subtilis. 2012 Appl. Biochem. Biotechnol. pmid:21537892
Gutsche KA et al. Production of volatile compounds by Lactobacillus sakei from branched chain α-keto acids. 2012 Food Microbiol. pmid:22202876
Li S et al. Improved 2-methyl-1-propanol production in an engineered Bacillus subtilis by constructing inducible pathways. 2012 Biotechnol. Lett. pmid:22941373
Huisman FH et al. Removal of the C-terminal regulatory domain of α-isopropylmalate synthase disrupts functional substrate binding. 2012 Biochemistry pmid:22352945
Beaudet AL Neuroscience. Preventable forms of autism? 2012 Science pmid:23087240
Novarino G et al. Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. 2012 Science pmid:22956686
Zhang T et al. Cloning and characterization of a novel 2-ketoisovalerate reductase from the beauvericin producer Fusarium proliferatum LF061. 2012 BMC Biotechnol. pmid:22916830
Lamsen EN and Atsumi S Recent progress in synthetic biology for microbial production of C3-C10 alcohols. 2012 Front Microbiol pmid:22701113
Ensminger AW et al. Experimental evolution of Legionella pneumophila in mouse macrophages leads to strains with altered determinants of environmental survival. 2012 PLoS Pathog. pmid:22693450
Liu Z et al. Complete Genome of Ignavibacterium album, a Metabolically Versatile, Flagellated, Facultative Anaerobe from the Phylum Chlorobi. 2012 Front Microbiol pmid:22661972
Zhou M et al. Tissue-specific and nutrient regulation of the branched-chain α-keto acid dehydrogenase phosphatase, protein phosphatase 2Cm (PP2Cm). 2012 J. Biol. Chem. pmid:22589535
Hu W et al. Selective editing of Val and Leu methyl groups in high molecular weight protein NMR. 2012 J. Biomol. NMR pmid:22532128
Qu SQ et al. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22433398
Chanumolu SK et al. UniDrug-target: a computational tool to identify unique drug targets in pathogenic bacteria. 2012 PLoS ONE pmid:22431985
van Leeuwen BN et al. Fermentative production of isobutene. 2012 Appl. Microbiol. Biotechnol. pmid:22234536
Friedrich T et al. Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease. 2012 Dis Model Mech pmid:22046030
Xiong M et al. A bio-catalytic approach to aliphatic ketones. 2012 Sci Rep pmid:22416247
Zhang D et al. A novel ion-pair RP-HPLC method for determination of five components in compound α-ketoacid tablets. 2012 J Pharm Biomed Anal pmid:22510314
Wang YP et al. Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). 2012 Gene pmid:22326532
Savrasova EA et al. Use of the valine biosynthetic pathway to convert glucose into isobutanol. 2011 J. Ind. Microbiol. Biotechnol. pmid:21161324
Li S et al. Engineering Bacillus subtilis for isobutanol production by heterologous Ehrlich pathway construction and the biosynthetic 2-ketoisovalerate precursor pathway overexpression. 2011 Appl. Microbiol. Biotechnol. pmid:21533914
Gong L et al. Characterization of organic anion-transporting polypeptide (Oatp) 1a1 and 1a4 null mice reveals altered transport function and urinary metabolomic profiles. 2011 Toxicol. Sci. pmid:21561886
van den Akker CH et al. Amino acid metabolism in the human fetus at term: leucine, valine, and methionine kinetics. 2011 Pediatr. Res. pmid:21857387
Adams SH Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. 2011 Adv Nutr pmid:22332087
Zhang W et al. The fur transcription regulator and fur-regulated genes in Clostridium botulinum A ATCC 3502. 2011 J. Biomed. Biotechnol. pmid:22203788
Chung JH et al. Proteomic and biochemical analyses reveal the activation of unfolded protein response, ERK-1/2 and ribosomal protein S6 signaling in experimental autoimmune myocarditis rat model. 2011 BMC Genomics pmid:22014063
Lowe CD et al. The transcriptome of the novel dinoflagellate Oxyrrhis marina (Alveolata: Dinophyceae): response to salinity examined by 454 sequencing. 2011 BMC Genomics pmid:22014029
Diebold AR et al. Activation of α-keto acid-dependent dioxygenases: application of an {FeNO}7/{FeO2}8 methodology for characterizing the initial steps of O2 activation. 2011 J. Am. Chem. Soc. pmid:21981763
Li JV et al. Metabonomic investigation of single and multiple strain Trypanosoma brucei brucei infections. 2011 Am. J. Trop. Med. Hyg. pmid:21212208
de Kraker JW and Gershenzon J From amino acid to glucosinolate biosynthesis: protein sequence changes in the evolution of methylthioalkylmalate synthase in Arabidopsis. 2011 Plant Cell pmid:21205930
Brunetti-Pierri N et al. Phenylbutyrate therapy for maple syrup urine disease. 2011 Hum. Mol. Genet. pmid:21098507
Park HD et al. Three Korean patients with maple syrup urine disease: four novel mutations in the BCKDHA gene. 2011 Ann. Clin. Lab. Sci. pmid:21844576
Mescka C et al. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease. 2011 Metab Brain Dis pmid:21380499